SynthesisMedical oncology (Northwood, London, England)2011

Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials.

Ezzeldin M Ibrahim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.